Jiangxi Dongbang Pharmaceutical's Acquisition

Jiangxi Dongbang Pharmaceutical was acquired by Porton Fine Chemicals on March 12, 2015.

Jiangxi Dongbang Pharmaceutical produces the intermediates of medicines used for cardiovascular diseases and AIDS, such as Atazanavir, Saquinavir, Fosamprenavir, Darunavir and contrast agent--Iopamido…

Articles about Jiangxi Dongbang Pharmaceutical's Acquisition: